Is routine screening for melanoma a benign practice?

JAMA

Volumn 284, Issue 7, 2000, Pages 883-886

  Edman, R L ^a   Klaus, S N ^a  

^a NONE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CANADA; CANCER INCIDENCE; CANCER SCREENING; DYSPLASTIC NEVUS; EARLY DIAGNOSIS; HISTOPATHOLOGY; HUMAN; MASS SCREENING; MELANOMA; PRIORITY JOURNAL; REVIEW; SKIN EXAMINATION; UNITED STATES;

EID: 0034675057     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.284.7.883     Document Type: Review

References (23)

1. Skin cancer screening
2. Years of potential life lost: Another indicator of the impact of cutaneous malignant melanoma on society
3. Diagnosis and treatment of early melanoma
4. Evidence-based practice guidelines from the US Preventive Services Task Force
5. The melanoma epidemic: Is increased surveillance the solution or the problem?
6. Temporal change in diagnostic criteria as a cause of the increase in malignant melanoma over time is unlikely
7. Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists
8. Discordance among expert pathologists in diagnosis of melanocytic neoplasms
9. Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions
10. Reliability of the histopathologic diagnosis of melanocytic dysplasia
11. Quality of care in the diagnosis of melanoma and related melanocytic lesions
12. Atypical mole syndrome: Risk factor for cutaneous malignant melanoma and implications for management
13. Interobserver concordance in discriminating clinical atypia of melanocytic nevi, and correlations with histologic atypia
14. Audit of public education campaign to encourage earlier detection of malignant melanoma
15. Melanoma: Prevention and early diagnosis
16. Prevention and early detection of malignant melanoma
17. Accelerated detection with prospective surveillance for cutaneous malignant melanoma in high-risk groups
18. Melanoma risk in individuals with clinically atypical nevi
19. Risk factors for melanoma incidence in prospective follow up: The importance of atypical (dysplastic) nevi
20. Dysplastic nevi: Markers for increased risk for melanoma
21. Who is being screened for melanoma/skin cancer? characteristics of persons screened in Massachusetts